Universität Münster — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Universität Münster appears in 10 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials10

Recruiting shown4

Roles2

SourceClinicalTrials.gov

Clinical trials

10 shown

Multimodal Imaging With FAPI-PET/MRI in Breast Carcinoma-In-Situ for Detection of Occult Invasive CancerNCT06540872 · lead sponsor · 2026-02-20

RECRUITING

Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple SclerosisNCT05920018 · lead sponsor · 2023-10-02

UNKNOWN

Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical ProstatectomyNCT04295447 · lead sponsor · 2020-12-10

ACTIVE_NOT_RECRUITING

Utilizing Smart Devices to Identify New Phenotypical Characteristics in Movement DisordersNCT03638479 · lead sponsor · 2019-01-08

COMPLETED

Respiratory Muscle Strength and Function in Neuromuscular Disorders and Chronic Obstructive Pulmonary DiseaseNCT03032562 · lead sponsor · 2016-12-01

UNKNOWN

Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment FailureNCT05603104 · collaborator · 2025-04-27

RECRUITING

The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.NCT05973851 · collaborator · 2024-08-31

RECRUITING

The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.NCT05958875 · collaborator · 2024-08-01

RECRUITING

Multimodal Intervention for Painful Diabetic Neuropathy: NeuOst Feasibility TrialNCT06423391 · collaborator · 2024-04-30

UNKNOWN

Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative DiseasesNCT05538455 · collaborator · 2022-09-30

COMPLETED

Drugs studied in this sponsor's trials

10 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Universität Münster as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

clozapine2

esketamine hydrochloride2

ketamine hydrochloride2

apalutamide 60 MG Oral Tablet1

bupropion1

escitalopram1

lithium1

quetiapine1

Sponsor roles

collaborator5

lead sponsor5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.